We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

39 hedge funds and large institutions have $13.7M invested in Galera Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,075% more call options, than puts

Call options by funds: $367K | Put options by funds: $4K

17% less funds holding

Funds holding: 47 → 39 (-8)

49% less capital invested

Capital invested by funds: $26.9M → $13.7M (-$13.1M)

72% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 18

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
39
Holders Change
-8
Holders Change %
-17.02%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
18
Closed
9
Calls
$367K
Puts
$4K
Net Calls
+$363K
Net Calls Change
-$604K

Top Buyers

Rank Fund Capital Flow
1
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$192K
2
BCM
Bridgeway Capital Management
Texas
+$68.5K
3
Citigroup
Citigroup
New York
+$19.9K
4
VF
Virtu Financial
New York
+$3.48K
5
US Bancorp
US Bancorp
Minnesota
+$3.42K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$337K
2
Citadel Advisors
Citadel Advisors
Florida
-$210K
3
Belvedere Trading
Belvedere Trading
Illinois
-$207K
4
Two Sigma Investments
Two Sigma Investments
New York
-$174K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$170K
Name Holding Trade Value Shares
Change 		Change in
Stake
TWMP
26
Taylor Wealth Management Partners
Massachusetts
$14K -$1.6K -935 -8%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$12K -$74 -43 -0.5%
TWA
28
TCI Wealth Advisors
Arizona
$8K – – –
Morgan Stanley
29
Morgan Stanley
New York
$6K -$2.47K -1,441 -26%
US Bancorp
30
US Bancorp
Minnesota
$4K +$3.42K +2,000 +145%
Bank of America
31
Bank of America
North Carolina
$3K -$3.27K -1,907 -40%
Wells Fargo
32
Wells Fargo
California
$3K +$10 +6 +0.3%
FDCDDQ
33
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.73K – – –
Simplex Trading
34
Simplex Trading
Illinois
$2K -$28.8K -16,834 -91%
CG
35
Cutler Group
California
$2K -$171 -100 -6%
CAPTRUST Financial Advisors
36
CAPTRUST Financial Advisors
North Carolina
$1K – – –
FIA
37
FNY Investment Advisers
New York
$1K +$2.57K +1,500 New
Belvedere Trading
38
Belvedere Trading
Illinois
– -$207K -101,413 Closed
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
– -$90K -37,693 Closed
Group One Trading
40
Group One Trading
Illinois
– -$58.8K -34,353 Closed
OQS
41
Occudo Quantitative Strategies
Florida
– -$72K -30,442 Closed
SSA
42
Schonfeld Strategic Advisors
New York
– -$63K -26,600 Closed
Marshall Wace
43
Marshall Wace
United Kingdom
– -$43K -18,004 Closed
UBS Group
44
UBS Group
Switzerland
– -$15K -6,200 Closed
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
– -$15K -5,800 Closed
TRCT
46
Tower Research Capital (TRC)
New York
– -$3K -1,316 Closed
1
2

GRTX Hedge Fund Activity: Q2 2022 in Review

39 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q2 2022, worth a combined $13.7M — down 49% from $26.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of GRTX and 2 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 5 added.

The largest buyer was Ensign Peak Advisors, adding an estimated $192K. The largest seller was Renaissance Technologies, cutting an estimated $337K.

  • 39 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q2 2022, down from 47 in Q1 2022.
  • Funds reported $13.7M of Galera Therapeutics, Inc. Common Stock stock for Q2 2022, down 49% quarter-over-quarter.
  • 2 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q2 2022 and 9 closed out, a net change of -7 holders.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q2 2022 was Ensign Peak Advisors, an estimated $192K added.
  • The largest Galera Therapeutics, Inc. Common Stock seller in Q2 2022 was Renaissance Technologies, an estimated $337K sold.

Based on aggregated 13F filings for Q2 2022.